Neuroendocrine Carcinoma Treatment Market Poised to Exceed USD 4.3 Billion by 2034, Propelled by Precision Medicine, Immunotherapy Breakthroughs
The global neuroendocrine carcinoma (NEC) treatment market is set for substantial growth, with an estimated